Chi-Med’s fruquintinib gets approval for colorectal cancer in China
Hutchison China MediTech (Chi-Med) has secured approval from the National Medical Products Administration of China...
Read More...
Focus:
-
Array BioPharma’s mCRC therapy gets breakthrough status
Array BioPharma has received breakthrough therapy designation from the US Food and Drug Administration (FDA)...
Read More...
Go Top
